Livechain Inc (LICH)

[timez1000]

The annual report specifically states Vyome Theurapeutics as the purchaser of the preferred shares, so I don't think that's in question that Vyome now owns the shell.

On August 31, 2021, the board of directors, by consent entered a Stock Purchase agreement with Vyome Therapeutics,
Inc., to sell to Vyome Therapeutics, Inc., 986,919 of the 996,919 of the company’s A-1 preferred shares. On the date of
closing, Vyome Therapeutics, Inc., purchased 996,919 shares of Livechain, Inc.’s, A-1 proffered stock, assuming
70.08% of the companies issued and outstanding shares. At the time of transfer, Venkat Nelabhotla, Chief Executive
Officer and Director of Vyome Therapeutics, Inc., also became Chief Executive Officer and Director of Livechain, Inc.